The aim of this study is the synergistic effect of cancer ablation and life information rehabilitation therapy on unresectable liver cancer.
By enrolling patients with unresectable liver cancer adapted to enrolled criteria, this study will document for the first time the synergistic effect of cancer ablation and life information rehabilitation therapy. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
120
Tumors bigger than 2 cm are fit for ablation therapy, percutaneously under CT scan or ultrasound.
Each treatment: one bottle solution each day, consecutive 3 months, oral administration
Fuda cancer institute of Fuda cancer hospital
Guangzhou, Guangdong, China
Relief degree of tumors
It will be evaluated by the Response Evaluation Criteria in Solid Tumors（RECIST）
Time frame: 3 months
Progress free survival（PFS）
The duration between treatment and cancer recurrence
Time frame: 1 year
Overall survival（OS）
The duration between treatment and patient pass away
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.